|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.75 USD | +2.08% |
|
+1.56% | +27.69% |
| 04/08 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
| 03/08 | UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.2TCr | |||||
| 19TCr | |||||
| 11TCr | |||||
| 6.12TCr | |||||
| 5.44TCr | |||||
| 4.82TCr |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
